March 10 (Reuters) - Illumina ( ILMN ) is reducing its
annual forecast and cutting $100 million in spending because
China barred sales of the company's gene-sequencing machines,
the Wall Street Journal reported on Monday, citing the company's
Chief Financial Officer Ankur Dhingra.